A
$ Value
$0
Shares
27,181
Price
$0
Filed
Jun 16
Insider
Name
SANDERS MACHELLE
Title
—
CIK
0001718020
Roles
Director
Transaction Details
Transaction Date
2025-06-12
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
27,181
Footnotes
Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant. | Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.
Filing Info
SANDERS MACHELLE's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-11-13 | BCRX | ▼ | $69K |
| 2025-06-12 | BCRX | A | $0 |
| 2025-06-12 | BCRX | A | $0 |
| 2025-06-10 | FTRE | A | $0 |
| 2025-05-14 | FTRE | M | $0 |
| 2025-05-14 | FTRE | M | $0 |
Other Insiders at BCRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MILANO VINCENT | — | — | 2026-02-27 |
| Stonehouse Jon P | — | — | 2026-03-02 |
| Frank Steven | — | — | 2026-02-27 |
|
Barnes Alane P
Chief Legal Officer
|
— | $1.4M | 2026-03-16 |
| Milne Jill C. | — | — | 2026-02-27 |
| HEGGIE THERESA | — | $505K | 2026-03-20 |
| McKee Amy E | — | — | 2026-02-27 |
|
Menon Sandeep
Chief R&D Officer
|
— | — | 2026-04-06 |